Expertise in
7
conditions

Jean-luc L. Houeto

Limoges, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Limoges, FR 
OverviewLocationsClinical Research

Overview

Jean-luc Houeto practices in Limoges, France. Mr. Houeto is highly rated in 7 conditions, according to our data. His top areas of expertise are Myoclonus-Dystonia, Movement Disorders, Parkinson's Disease, Palatal Myoclonus, and Deep Brain Stimulation.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Limoges, France
Other Locations
Equipe 01-Neuropsychologie Interventionnelle L'Institut Mondor De Recherches Biomédicales, Université Paris Est Créteil, UMR 1239, CIC 1413, CIC 1402, CNRS UMR 7104, CIC 1414, CHU De Caen, Caen, France
Poitiers, France
Avenue Maquis Du Grésivaudan, La Tronche, 38700, France
Bron, France
Paris, France
Clermont-ferrand, 63001, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Enrollment Status: Recruiting
Publish Date: January 29, 2024
Intervention Type: Other
Study Phase: Not Applicable
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
Brain Microglial Activation in the Early Stage of the Parkinson's Disease: a Predictive Biomarker of the Evolution?
Brain Microglial Activation in the Early Stage of the Parkinson's Disease: a Predictive Biomarker of the Evolution?
Enrollment Status: Active_not_recruiting
Publish Date: April 25, 2024
Intervention Type: Drug
Study Drug: [18F]DPA-714 PET scan
Study Phase: Phase 2
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2022
Intervention Type: Other
Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study
Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Other
Study Phase: Not Applicable
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Enrollment Status: Completed
Publish Date: February 05, 2021
Intervention Type: Drug
Study Phase: Phase 2
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Enrollment Status: Completed
Publish Date: February 06, 2020
Intervention Type: Procedure
Study Phase: Phase 3
View 7 Less Clinical Trials

55 Total Publications

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.
Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.
Journal: Movement disorders clinical practice
Published: February 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Houeto's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile